Tabac pour pipe à eau : Questions médicales fréquentes
Nom anglais: Tobacco, Waterpipe
Descriptor UI:D000073846
Tree Number:J01.637.767.844.750
Termes MeSH sélectionnés :
Patient Readmission
Questions fréquentes et termes MeSH associés
Diagnostic
2
#1
Comment diagnostiquer une dépendance au tabac à pipe à eau ?
Un diagnostic repose sur l'évaluation des habitudes de consommation et des symptômes de sevrage.
Dépendance au tabacDiagnostic médical
#2
Quels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?
Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets sur la santé.
Fonction pulmonaireTests diagnostiques
Symptômes
2
#1
Quels sont les symptômes d'une consommation excessive ?
Les symptômes incluent toux, essoufflement, fatigue et irritation des voies respiratoires.
TouxEssoufflement
#2
Comment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?
Il peut causer des maladies des gencives, des caries et des taches sur les dents.
Santé bucco-dentaireMaladies des gencives
Prévention
2
#1
Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?
L'éducation sur les risques et la promotion d'activités alternatives sont essentielles.
Prévention du tabagismeÉducation à la santé
#2
Quelles campagnes sont efficaces contre le tabac à pipe à eau ?
Les campagnes de sensibilisation et les restrictions publicitaires montrent des résultats positifs.
Campagnes de santé publiqueTabagisme
Traitements
2
#1
Quels traitements existent pour arrêter le tabac à pipe à eau ?
Les traitements incluent les thérapies comportementales et les substituts nicotiniques.
Thérapie comportementaleSubstituts nicotiniques
#2
Les médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?
Oui, des médicaments comme la varénicline peuvent réduire les envies de fumer.
VaréniclineMédicaments anti-tabac
Complications
2
#1
Quelles sont les complications respiratoires liées au tabac à pipe à eau ?
Les complications incluent bronchite chronique, emphysème et risque accru de cancer du poumon.
Bronchite chroniqueCancer du poumon
#2
Le tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?
Oui, il augmente le risque de maladies cardiovasculaires en affectant la circulation sanguine.
Maladies cardiovasculairesCirculation sanguine
Facteurs de risque
2
#1
Quels sont les principaux facteurs de risque du tabac à pipe à eau ?
Les facteurs incluent l'âge, le milieu social, et l'exposition à d'autres fumeurs.
Facteurs de risqueTabagisme
#2
Les femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?
Oui, cela peut nuire au développement fœtal et augmenter les complications de grossesse.
GrossesseTabagisme
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tabac pour pipe à eau : Questions médicales les plus fréquentes",
"headline": "Tabac pour pipe à eau : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tabac pour pipe à eau : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-20",
"dateModified": "2025-02-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tabac pour pipe à eau"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Produits du tabac",
"url": "https://questionsmedicales.fr/mesh/D062789",
"about": {
"@type": "MedicalCondition",
"name": "Produits du tabac",
"code": {
"@type": "MedicalCode",
"code": "D062789",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.767.844"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Tabac pour pipe à eau",
"alternateName": "Tobacco, Waterpipe",
"code": {
"@type": "MedicalCode",
"code": "D000073846",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Omar F Khabour",
"url": "https://questionsmedicales.fr/author/Omar%20F%20Khabour",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Applied Medical Sciences, Department of Laboratory Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan."
}
},
{
"@type": "Person",
"name": "Karem H Alzoubi",
"url": "https://questionsmedicales.fr/author/Karem%20H%20Alzoubi",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan."
}
},
{
"@type": "Person",
"name": "Erin L Sutfin",
"url": "https://questionsmedicales.fr/author/Erin%20L%20Sutfin",
"affiliation": {
"@type": "Organization",
"name": "Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA esutfin@wakehealth.edu."
}
},
{
"@type": "Person",
"name": "Jennifer Cornacchione Ross",
"url": "https://questionsmedicales.fr/author/Jennifer%20Cornacchione%20Ross",
"affiliation": {
"@type": "Organization",
"name": "Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA."
}
},
{
"@type": "Person",
"name": "Thomas Eissenberg",
"url": "https://questionsmedicales.fr/author/Thomas%20Eissenberg",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychology, Virginia Commonwealth University, Richmond, VA, United States of America."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Outcomes and Readmission in Patients With Retinal Artery Occlusion (from the Nationwide Readmission Database).",
"datePublished": "2022-09-14",
"url": "https://questionsmedicales.fr/article/36115725",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.amjcard.2022.07.040"
}
},
{
"@type": "ScholarlyArticle",
"name": "Thirty-Day Readmission Among Patients With Uncomplicated Choledocholithiasis: A Nationwide Readmission Database Analysis.",
"datePublished": "2023-07-01",
"url": "https://questionsmedicales.fr/article/35648885",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MCG.0000000000001724"
}
},
{
"@type": "ScholarlyArticle",
"name": "Readmission after OSA surgery in pediatric patients.",
"datePublished": "2022-09-23",
"url": "https://questionsmedicales.fr/article/36149489",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00405-022-07657-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Readmission rates in HIV-associated burkitt lymphoma patients in the USA: a nationwide readmission database (NRD) analysis.",
"datePublished": "2023-11-11",
"url": "https://questionsmedicales.fr/article/37951907",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12981-023-00575-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "The patient experience of a postpartum readmission for hypertension: a qualitative study.",
"datePublished": "2024-05-14",
"url": "https://questionsmedicales.fr/article/38745136",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12884-024-06564-2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Technologie, industrie et agriculture",
"item": "https://questionsmedicales.fr/mesh/D013676"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits manufacturés",
"item": "https://questionsmedicales.fr/mesh/D008420"
},
{
"@type": "ListItem",
"position": 4,
"name": "Dispositifs pour fumer",
"item": "https://questionsmedicales.fr/mesh/D000074602"
},
{
"@type": "ListItem",
"position": 5,
"name": "Produits du tabac",
"item": "https://questionsmedicales.fr/mesh/D062789"
},
{
"@type": "ListItem",
"position": 6,
"name": "Tabac pour pipe à eau",
"item": "https://questionsmedicales.fr/mesh/D000073846"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tabac pour pipe à eau - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tabac pour pipe à eau",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tabac pour pipe à eau",
"description": "Comment diagnostiquer une dépendance au tabac à pipe à eau ?\nQuels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Patient+Readmission#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tabac pour pipe à eau",
"description": "Quels sont les symptômes d'une consommation excessive ?\nComment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Patient+Readmission#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tabac pour pipe à eau",
"description": "Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?\nQuelles campagnes sont efficaces contre le tabac à pipe à eau ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Patient+Readmission#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tabac pour pipe à eau",
"description": "Quels traitements existent pour arrêter le tabac à pipe à eau ?\nLes médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Patient+Readmission#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tabac pour pipe à eau",
"description": "Quelles sont les complications respiratoires liées au tabac à pipe à eau ?\nLe tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Patient+Readmission#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tabac pour pipe à eau",
"description": "Quels sont les principaux facteurs de risque du tabac à pipe à eau ?\nLes femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Patient+Readmission#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dépendance au tabac à pipe à eau ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur l'évaluation des habitudes de consommation et des symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets sur la santé."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une consommation excessive ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, essoufflement, fatigue et irritation des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Comment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut causer des maladies des gencives, des caries et des taches sur les dents."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation sur les risques et la promotion d'activités alternatives sont essentielles."
}
},
{
"@type": "Question",
"name": "Quelles campagnes sont efficaces contre le tabac à pipe à eau ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les campagnes de sensibilisation et les restrictions publicitaires montrent des résultats positifs."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour arrêter le tabac à pipe à eau ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les thérapies comportementales et les substituts nicotiniques."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme la varénicline peuvent réduire les envies de fumer."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications respiratoires liées au tabac à pipe à eau ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent bronchite chronique, emphysème et risque accru de cancer du poumon."
}
},
{
"@type": "Question",
"name": "Le tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il augmente le risque de maladies cardiovasculaires en affectant la circulation sanguine."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du tabac à pipe à eau ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le milieu social, et l'exposition à d'autres fumeurs."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, cela peut nuire au développement fœtal et augmenter les complications de grossesse."
}
}
]
}
]
}
Mohammed Moumen, Medical Student, Wake Forrest School of Medicine, Winston-Salem, NC. Marielle Brinkman, Senior Research Scientist, Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH. Brittney Keller-Hamilton, Research Scientist, Comprehensive Cancer Center, The Ohio State University, Columbus, OH. Andreas A. Teferra, Doctoral Student, Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH. Megan E. Roberts, Assistant Professor, Division of Health Behavior and Health Promotion, College of Public Health, The Ohio State University, Columbus, OH. Elizabeth G. Klein, Interim Chair and Associate Professor, Division of Health Behavior and Health Promotion, College of Public Health, The Ohio State University, Columbus, OH. Paul Nini, Professor, Department of Design, College of Arts and Sciences, The Ohio State University, Columbus, OH. Michael Pennell, Associate Professor, Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH. Amy K. Ferketich, Professor Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH.
Department of Internal Medicine, The Ohio State University College of Medicine, Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States of America.
Department of Internal Medicine, The Ohio State University College of Medicine, Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States of America.
Retinal artery occlusion (RAO) is an ophthalmologic emergency, leading to sudden vision loss. Understanding its risk factors and garnering information on the incidence of adverse events can provide he...
We aimed to determine the rate of 30-day hospital readmissions of uncomplicated choledocholithiasis and its impact on mortality and health care use in the United States....
Nonelective admissions for adults with uncomplicated choledocholithiasis were selected from the Nationwide Readmission Database 2016-2018. The primary outcome was the all-cause 30-day readmission rate...
The 30-day rate of readmission was 9.3%. Biliary and pancreatic disorders and postprocedural complications accounted for 36.6% and 10.3% of readmission, respectively. The mortality rate among patients...
The uncomplicated choledocholithiasis 30-day readmission rate is 9.3%. Readmission was associated with higher mortality, morbidity, and resource use. Multiple independent predictors of readmission wer...
This study aimed to determine the readmission rate after adenotonsillectomy with the diagnosis of obstructive sleep apnea (OSA) and analyze the factors associated with readmission....
It was planned as a retrospective study conducted in a single institution that included pediatric patients who underwent adenotonsillectomy with OSA diagnosis between December 2018 and March 2021. Pat...
The mean postoperative admission time was 7.27 ± 3.49 days in patients with bleeding and 3.5 ± 2.27 days in patients with pain or dehydration. The mean length of stay in the hospital was 2.6 ± 1.6 day...
In children who underwent adenotonsillectomy for OSA, the hospitalization period of patients hospitalized due to pain/dehydration is much longer than patients admitted with bleeding. Therefore, measur...
People with human immunodeficiency virus have an increased risk of developing AIDS-defining malignancies including Burkitt lymphoma. Survival outcomes in HIV-associated Burkitt lymphoma remain worse t...
Data were abstracted from the 2010-2020 Nationwide Readmissions Database; hospitalizations included patients with a primary BL diagnosis and were stratified by comorbid HIV. The primary outcome was al...
Overall, there were 8,453 hospitalizations for BL and 6.0% carried an HIV diagnosis. Of BL hospitalizations, 68.4% were readmitted within 30-days post index BL hospitalization and 6.8% carried a HIV d...
HIV-positive status is associated with an increased risk for 30-day readmission after index hospitalization for Burkitt lymphoma....
Hypertensive disorders of pregnancy (HDP) are the most common cause of postpartum readmission. Prior research led to clinical guidelines for postpartum management; however, the patient experience is o...
This was a qualitative study with data generated through semi-structured interviews. Patients readmitted with postpartum HDP at an urban academic medical center from February to December 2022 were app...
Six themes were generated: every pregnancy is different, symptoms of preeclampsia are easily dismissed or minimized by both patient and providers, miscommunication regarding medical changes can increa...
This qualitative research study revealed patient-identified gaps in care that may have led to readmission for hypertensive disorders of pregnancy. The specific recommendations that emerge from these t...
We sought to examine readmission rates and predictors of hospital readmission following TAVR in patients with ESRD....
End-stage renal disease (ESRD) is associated with poor outcomes following transcatheter aortic valve replacement (TAVR)....
We assessed index hospitalizations for TAVR from the National Readmissions Database from 2017 to 2018 and used propensity scores to match those with and without ESRD. We compared 90-day readmission fo...
We identified 49,172 index hospitalizations for TAVR, including 1,219 patients with ESRD (2.5%). Patient with ESRD had higher rates of all-cause readmission (34.4% vs. 19.2%, HR 1.96, 95% CI 1.68-2.30...
Patients with ESRD undergoing TAVR have higher mortality and increased cost associated with their index hospitalization and are at increased risk of readmission within 90 days following TAVR....
Hospital readmissions following acute myocardial infarction (AMI) pose a significant economic burden on health care utilization. The hospital readmission reduction program (HRRP) enacted in 2012 focus...
There is a scarcity of national population-based studies on polymyositis (PM)/dermatomyositis (DM) readmissions in the USA. In this study, we aim to describe the rates, reasons for readmissions, and c...
We analyzed the 2018 Nationwide Readmissions Database (NRD). We included index hospitalizations for all adult DM/PM patients with a principal diagnosis of PM/DM using ICD-10 codes. We excluded electiv...
A total of 1610, 1286, and 842 index hospitalizations with a principal diagnosis of PM/DM, that were discharged alive, were included in the 30-, 90-, and 180-day readmission analysis, respectively. Am...
About a third of PM/DM hospitalized patients are readmitted within 180 days. Readmissions constitute a significant economic burden to the health care system. PM and sepsis are the main reasons for rea...
This review aims to summarize the current burden of heart failure (HF) in the United States, specifically in patients with low socioeconomic position (SEP), and synthesize recommendations to prevent H...
As treatments have improved, HF-related mortality has declined over time, resulting in more patients living with HF. This has led to an increase in hospitalizations, however, putting excess strain on ...
Care navigation is commonly used to reduce preventable hospitalisation. The use of Electronic Health Record-derived algorithms may enable better targeting of this intervention for greater impact....
To evaluate if community-based Targeted Care Navigation, supported by an Electronic Health Record-derived readmission risk algorithm, is associated with reduced rehospitalisation....
A propensity score matching cohort (5 comparison to 1 intervention cohort ratio) study was conducted in an 850-bed Victorian public metropolitan health service, Australia, from May to November 2017. A...
Sixty-five recipients received care navigation and were matched to 262 people who did not receive care navigation. Excellent matching was achieved with standardised differences between groups being <0...
We provide preliminary evidence that Targeted Care Navigation supported by an Electronic Health Record-derived readmission risk algorithm may reduce 30-day hospital readmissions....
